APPLICATION
ANDA076870
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-26
LATEST ACTION
2026-03-13
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ALLOPURINOL SODIUMPrescription
ALLOPURINOL SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2026-03-13Manufacturing (CMC) · Supplement 11 · standardAP
2026-03-13Manufacturing (CMC) · Supplement 10 · standardAP
2016-09-09Manufacturing (CMC) · Supplement 9 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.